Clinical Trial Update: A Study of Rovalpituzumab Tesirine Administered in Combination With Nivolumab and With or Without Ipilimumab for Adults With Extensive-Stage Small Cell Lung Cancer [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial investigating rovalpituzumab tesirine in combination with nivolumab, with or without ipilimumab, in adults with extensive-stage small cell lung c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• ipilimumab (ipilimumab)
• nivolumab (nivolumab)
• rovalpituzumab tesirine (rovalpituzumab tesirine)

Snippet

Sponsor: AbbVie | Conditions: Small Cell Lung Cancer | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2020-07-01